No company matches — see all tickers
President and COO Spencer Stiles will succeed Kevin Lobo as CEO in January 2027; Lobo moves to Executive Chair.
Tariff reversal boosted GAAP earnings alongside volume-led MedSurg and Orthopaedics growth; H1 adjusted operating margin stayed broadly flat.
Higher unit volume drove MedSurg/Neurotechnology and Orthopaedics growth; cyber recovery progressed and FY2026 guidance narrowed.
Coverage: 10-K, 10-Q and 8-K filings filed since Jul 9, 2026.
Request longer coverage
Company data: Wikidata Q2357515
We read every message.